Latest News about EXEL
Recent news which mentions EXEL
2 Growth Stocks That Could Double in the Next Year
September 19, 2022
From Motley Fool
Exelixis' XL092/ Atezolizumab Shows Encouraging Efficacy, Safety In Heavily Pretreated Cancer Patients
September 12, 2022
Tickers
EXEL
From Benzinga
Exelixis Announces Detailed Results From Late-Stage Cabometyx Combo Trial In Kidney Cancer
September 08, 2022
Tickers
EXEL
From Benzinga
From Motley Fool
2 No-Brainer Bio-Tech Stocks to Buy Right Now
August 13, 2022
From Motley Fool
Biotech Daily: Regulatory Setback For CorMedix, Mersana & GSK In Cancer Pact, BARDA Funding For Opioid Overdose Hopeful
August 09, 2022
From Benzinga
2 Top Biotech Stocks Defying the Bear Market
August 06, 2022
From Motley Fool
From Motley Fool
3 Stocks That Are Fantastic Deals Right Now
July 28, 2022
From Motley Fool
7 Undervalued Biotech Stocks to Buy Before They Boom
July 25, 2022
From InvestorPlace
2 Biotech Stocks to Help Recession-Proof Your Portfolio
July 22, 2022
From Motley Fool
1 Reason to Buy Exelixis Stock, and 1 Reason to Sell
July 22, 2022
From Motley Fool
7 Best Biotech Stocks to Buy in July 2022
July 08, 2022
From InvestorPlace
From Benzinga
3 Beaten-Down Growth Stocks to Buy Now and Hold Forever
July 01, 2022
From Motley Fool
2 Biotech Stocks That Could Make You Richer
June 26, 2022
From Motley Fool
From Benzinga
From Motley Fool
From Benzinga
From Benzinga
Exelixis-BioInvent Establish Immuno-Oncology Pact
June 16, 2022
From Benzinga
From Motley Fool
From InvestorPlace
From Benzinga
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
